Evidence map›Paper›PMID 36789086›Full record

ArticleBio-protocol2023

Sample Preparation and Integrative Data Analysis of a Droplet-based Single-Cell ATAC-sequencing Using Murine Thymic Epithelial Cells.

Tatsuya Ishikawa, Hiroto Ishii, Takahisa Miyao, Kenta Horie, Maki Miyauchi, Nobuko Akiyama, Taishin Akiyama

Abstract read
In one paragraph

Article in Bio-protocol, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tatsuya IshikawaLaboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Hiroto IshiiLaboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Takahisa MiyaoLaboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Kenta HorieLaboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Maki MiyauchiLaboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Nobuko AkiyamaLaboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Taishin AkiyamaLaboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accessible chromatin regions modulate gene expression by acting as cis-regulatory elements. Understanding the epigenetic landscape by mapping accessible regions of DNA is therefore imperative to decipher mechanisms of gene regulation under specific biological contexts of interest. The assay for transposase-accessible chromatin sequencing (ATAC-seq) has been widely used to detect accessible chromatin and the recent introduction of single-cell technology has increased resolution to the single-cell level. In a recent study, we used droplet-based, single-cell ATAC-seq technology (scATAC-seq) to reveal the epigenetic profile of the transit-amplifying subset of thymic epithelial cells (TECs), which was identified previously using single-cell RNA-sequencing technology (scRNA-seq). This protocol allows the preparation of nuclei from TECs in order to perform droplet-based scATAC-seq and its integrative analysis with scRNA-seq data obtained from the same cell population. Integrative analysis has the advantage of identifying cell types in scATAC-seq data based on cell cluster annotations in scRNA-seq analysis.

Indexed as

Integrative single cell analysisNuclei isolationSingle-cell ATAC-seqSingle-cell RNA sequencingThymic epithelial cellsThymus

Identifiers

PMID36789086
PMCPMC9901465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.